TDP-43 loss induces cryptic polyadenylation in ALS/FTD

Sam Bryce-Smith(Queen Mary University of London), Anna‐Leigh Brown(Queen Mary University of London), Max Z. Y. J. Chien(Queen Mary University of London), Dario Dattilo(Queen Mary University of London), Puja R. Mehta(Queen Mary University of London), Francesca Mattedi(Queen Mary University of London), Simone Barattucci(Queen Mary University of London), Alla Mikheenko(Queen Mary University of London), Matteo Zanovello(Queen Mary University of London), Flaminia Pellegrini(Queen Mary University of London), Sara Emad El-Agamy(Queen Mary University of London), Matthew Yome(Queen Mary University of London), Sarah E. Hill(National Institutes of Health), Yue Qi(National Institutes of Health), Kai Sun(Queen Mary University of London), Eugeni Ryadnov(Queen Mary University of London), Yixuan Wan(Queen Mary University of London), Hemali Phatnani(New York Genome Center), Justin Kwan(University of Maryland, Baltimore), Dhruv Sareen(Cedars-Sinai Medical Center), James R. Broach(Pennsylvania State University), Zachary Simmons(Pennsylvania State University), Ximena Arcila-Londono(Henry Ford Health System), Edward B. Lee(University of Pennsylvania), Vivianna M. Van Deerlin(University of Pennsylvania), Neil A. Shneider(Columbia University), Ernest Fraenkel(Massachusetts Institute of Technology), Lyle W. Ostrow(Johns Hopkins University), Frank Baas(Leiden University Medical Center), Noah Zaitlen(University of California, San Francisco), James D. Berry(Harvard University), Andrea Malaspina(Queen Mary University of London), Gregory A. Cox(Jackson Laboratory), Leslie M. Thompson(University of California, Irvine), Steven Finkbeiner(Gladstone Institutes), Efthimios Dardiotis(University of Thessaly), Timothy M. Miller(Washington University in St. Louis), Siddharthan Chandran(MRC Centre for Regenerative Medicine), Suvankar Pal(MRC Centre for Regenerative Medicine), Eran Hornstein(Weizmann Institute of Science), Daniel J. MacGowan(Icahn School of Medicine at Mount Sinai), Terry Heiman‐Patterson(Temple University), Molly Hammell(Cold Spring Harbor Laboratory), Nikolaos A. Patsopoulos(Broad Institute), Josh Dubnau(Stony Brook University), Avindra Nath(National Institutes of Health), Robert Bowser(Barrow Neurological Institute), Matthew B. Harms(Columbia University), Eleonora Aronica(Amsterdam UMC Location University of Amsterdam), Mary Poss(Pennsylvania State University), Jennifer E. Phillips‐Cremins(New York Stem Cell Foundation), John F. Crary(Allen Institute for Brain Science), Nazem Atassi(Harvard University), Dale J. Lange(Hospital for Special Surgery), Darius J. Adams(Overlook Medical Center), Leonidas Stefanis(National and Kapodistrian University of Athens), Marc Gotkine(Hebrew University of Jerusalem), Robert H. Baloh(Cedars-Sinai Medical Center), Suma Babu(Massachusetts General Hospital), Sabrina Paganoni(Harvard University), Ophir Shalem(Children's Hospital of Philadelphia), Colin Smith(Mott MacDonald (United Kingdom)), Bin Zhang(Icahn School of Medicine at Mount Sinai), Justin Kwan(University of Maryland, Baltimore), Thomas G. Blanchard(University of Maryland, Baltimore), Brent T. Harris(Georgetown University), Iris Broce(University of California, San Francisco), Vivian E. Drory(Tel Aviv University), John Ravits(University of California San Diego), Corey T. McMillan(University of Pennsylvania), Vilas Menon(Columbia University Irving Medical Center), Lani F. Wu(University of California, San Francisco), Steven J. Altschuler(University of California, San Francisco), Yossef Lerner, Rita Sattler(Barrow Neurological Institute), Kendall Van Keuren‐Jensen(Translational Genomics Research Institute), Orit Rozenblatt–Rosen(Broad Institute), Kerstin Lindblad‐Toh(Broad Institute), Katharine Nicholson(Massachusetts General Hospital), Peter K. Gregersen(Northwell Health), Jeong‐Ho Lee(Korea Advanced Institute of Science and Technology), Oleg Butovsky(Brigham and Women's Hospital), Matt Brauer(Maze (United States)), T. Nickerson(Maze (United States)), Shameek Biswas(Bristol-Myers Squibb (United States)), Kimberly Wilson(Bristol-Myers Squibb (United States)), Sulev Kõks(Perron Institute for Neurological and Translational Science), Stephen Muljo(National Institute of Allergy and Infectious Diseases), Bryan J. Traynor(National Institute on Aging), Robert Moccia(Pfizer (United States)), Seng H. Cheng(Pfizer (United States)), Andrew Deubler(Regeneron (United States)), Giovanni Coppola(Regeneron (United States)), Mickey Atwal(Regeneron (United States)), Michael Cantor(Regeneron (United States)), William Salerno(Regeneron (United States)), Eli A. Stahl(Regeneron (United States)), Matt Anderson(Regeneron (United States)), David Frendewey(Regeneron (United States)), Daphne Koller, Mary Rozenman, Jose Norberto S. Vargas(Queen Mary University of London), Nicol Birsa(Queen Mary University of London), Towfique Raj(Allen Institute for Brain Science), Jack Humphrey(Allen Institute for Brain Science), Matthew J. Keuss(Queen Mary University of London), Oscar G. Wilkins(Queen Mary University of London), Michael E. Ward(National Institutes of Health), Maria Secrier(Institute of Genetics), Pietro Fratta(Queen Mary University of London)
Nature Neuroscience
October 21, 2025
Cited by 18Open Access
Full Text

Abstract

Nuclear depletion and cytoplasmic aggregation of the RNA-binding protein TDP-43 are cellular hallmarks of amyotrophic lateral sclerosis (ALS). TDP-43 nuclear loss causes de-repression of cryptic exons, yet cryptic alternative polyadenylation (APA) events have been largely overlooked. In this study, we developed a bioinformatic pipeline to reliably identify alternative last exons, 3' untranslated region (3'UTR) extensions and intronic polyadenylation APA event types, and we identified cryptic APA sites induced by TDP-43 loss in induced pluripotent stem cell (iPSC)-derived neurons. TDP-43 binding sites are enriched at sites of these cryptic events, and TDP-43 can both repress and enhance APA. All categories of cryptic APA were also identified in ALS and frontotemporal dementia (FTD) postmortem brain tissue. RNA sequencing (RNA-seq), thiol(SH)-linked alkylation for the metabolic sequencing of RNA (SLAM-seq) and ribosome profiling (Ribo-seq) revealed that distinct cryptic APA categories have different downstream effects on transcript levels and that cryptic 3'UTR extensions can increase RNA stability, leading to increased translation. In summary, we demonstrate that TDP-43 nuclear depletion induces cryptic APA, expanding the palette of known consequences of TDP-43.


Related Papers

No related papers found

Powered by citation graph analysis